Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Intuniv in Children With Tic Disorders
NCT01547000Phase 4Completed
- Sponsor
- Yale University
- Start
- Apr 2012
- Primary completion
- Dec 2016
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of guanfacine in Tourette syndrome (TS), chronic motor or vocal tic disorder, sponsored by Yale University. Started Apr 2012; status: completed.
02
Drugs
guanfacine
03
Conditions
Tourette syndrome (TS)chronic motor or vocal tic disorder
Beyond the preview
Go deeper on NCT01547000.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01547000.